Возраст домена | 13 лет |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | |
Страниц в Google | 73 |
Страниц в Яндексе | 1 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | Нет данных |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Home – Teva Pharmaceuticals in the US
n/a
As a manufacturer of brand and generic pharmaceuticals, Teva is working every day to make quality healthcare accessible.
UTF-8
30.92 КБ
444
3 714 симв.
3 174 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
tevapharm.com | 84 | 6 |
80 | 245513 | 160700 | |
teva.com | 79 | 5 |
20 | 56690 | 19352 | |
tevagenerics.com | 68 | 5 |
0 | 783523 | 274876 | |
icims.com | 48 | 6 |
40 | 1602 | 471 | |
wikipedia.org | 48 | 9 |
0 | 5 | 6 | |
yahoo.com | 37 | 9 |
0 | 9 | 7 | |
google.com | 36 | 9 |
0 | 1 | 1 | |
indeed.com | 34 | 8 |
0 | 138 | 50 | |
bloomberg.com | 31 | 8 |
0 | 563 | 219 | |
seekingalpha.com | 26 | 6 |
0 | 1742 | 416 | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 16 Апреля 2016 ) | |
Количество ссылок на сайт | 260 |
Количество доменов, которые ссылаются на сайт | 47 |
Количество найденных анкоров | 21 |
Исходящие (внешние) ссылки домена | 102 |
Количество доменов, на которые ссылается сайт | 31 |
Количество исходящих анкоров | 12 |
Внешние ссылки главной страницы ( 20 ) | |
facebook.com/TevaUSA | <img> |
linkedin.com/company/5239 | <img> |
twitter.com/TevaUSA | <img> |
tevagenerics.com/returngoodspolicy | Return Goods Policy |
tevagenerics.com/termsandconditions | Terms and Conditions |
news.tevausa.com/phoenix.zhtml?c=251945&p=irol-news&nyo=0 | News |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-contact | Media Contacts |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-factsheet | Fast Facts |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-faq | Media FAQ |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-newsArtic... | Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfate 117 ... |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-newsArtic... | Celltrion and Teva Announce FDA Approval of HERZUMA® (trastuzumab-pkrb), a Biosimilar to HERCEPTIN®, for the Treatment of HER2-O... |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-newsArtic... | Celltrion and Teva Announce FDA Approval of TRUXIMA® (rituximab-abbs), a Biosimilar to RITUXAN®, for Three Non-Hodgkin’s Lymphom... |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-newsArtic... | Teva’s Generic Version of EpiPen® (Epinephrine Injection, USP) Auto-Injector 0.3 mg Now Available in Limited Quantity in the Uni... |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-newsArtic... | Statement: Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets and Amlod... |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-newsArtic... | Statement: CVS Caremark formulary coverage for AJOVY™ (fremanezumab-vfrm) injection |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-newsArtic... | Teva Reports Third Quarter 2018 Financial Results |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-newsArtic... | Statement: ESI decision regarding formulary coverage for AJOVY™ (fremanezumab-vfrm) injection |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-newsArtic... | Celltrion and Teva Announce FDA Oncologic Drugs Advisory Committee Recommends Approval of Celltrion BLA for CT-P10, a Proposed R... |
phx.corporate-ir.net/phoenix.zhtml?c=251945&p=irol-newsArtic... | Teva to Report Third Quarter 2018 Financial Results on November 1, 2018 |
nabp.net/programs/accreditation/vawd/ | <img> |
Внутренние ссылки главной страницы ( 36 ) | |
../../Default.aspx | Pharmaceutical Industries Limited |
Company.aspx | Company |
TevaGlobal.aspx | Teva Global |
History.aspx | History |
SpecialtyAreas.aspx | Specialty Areas |
CNS.aspx | CNS |
Oncology.aspx | Oncology |
Respiratory.aspx | Respiratory |
SelectBrands.aspx | Select Brands |
Diversity.aspx | Inclusion And Diversity |
InclusionNetwork.aspx | Teva Inclusion Network |
Contact.aspx | Contact |
Medicines.aspx | Medicines |
SpecialtyMedicines.aspx | Specialty Medicines |
GenericMedicines.aspx | Generic Medicines |
MedicalAffairs.aspx | Medical Affairs |
MedicalInformation.aspx | Medical Information |
MedicalEducation.aspx | Medical Education |
QualitySafety.aspx | Quality + Safety |
TradePartners.aspx | Trade Partners |
Responsibility.aspx | Responsibility |
CorpSocialResponsibility.aspx | Responsibility |
CorpCharitableDonations.aspx | Our Giving |
AccessToMedicine.aspx | Access to Medicine |
Volunteerism.aspx | Partnerships and Volunteerism |
How-to-apply.aspx | How to Apply |
Advocacy.aspx | Advocacy |
Compliance.aspx | Compliance |
Relationships.aspx | Releationships With HCPs |
Careers.aspx | Careers |
CareersFAQ.aspx | Careers FAQ |
TevaExperience.aspx | The Teva Experience |
PrivacyPolicy.aspx | Privacy |
LegalNotice.aspx | Legal |
socialguidelines.aspx | Social |
Sitemap.aspx | Sitemap |
Domain Name: TEVAPHARM-NA.COM
Registry Domain ID: 1600646317_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.comlaude.com
Registrar URL: http://www.comlaude.com
Updated Date: 2018-06-07T04:26:56Z
Creation Date: 2010-06-04T21:47:36Z
Registry Expiry Date: 2019-06-04T21:47:36Z
Registrar: Nom-iq Ltd. dba COM LAUDE
Registrar IANA ID: 470
Registrar Abuse Contact Email: abuse@comlaude.com
Registrar Abuse Contact Phone: +44.2074218250
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS3.TEVAPHARM.COM
Name Server: NS4.TEVAPHARM.COM
Name Server: NS5.TEVAPHARM.COM
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-12-11T09:24:48Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
208.93.140.80
HTTP/1.1 200 OK
Cache-Control: private
Content-Type: text/html; charset=utf-8
Server: Microsoft-IIS/7.5
Set-Cookie: __AntiXsrfToken=37b773cc8e3e4a20ad0e57ec04d84bf4; path=/; HttpOnly
X-XSS-Protection: 1; mode=block
X-Frame-Options: sameorigin
X-Content-Type-Options: nosniff
Date: Fri, 28 Dec 2018 16:41:00 GMT
Content-Length: 31665
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"